comparemela.com

Latest Breaking News On - Blueprint medicines corporation - Page 1 : comparemela.com

Investors Have the Opportunity to Join the Following Securities Fraud Investigations: Avangrid, Inc (AGR), Squarespace, Inc (SQSP), and Blueprint Medicines Corporation (BPMC)

Investors Have the Opportunity to Join the Following Securities Fraud Investigations: Avangrid, Inc (AGR), Squarespace, Inc (SQSP), and Blueprint Medicines Corporation (BPMC)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Avidity Partners Management LP Decreases Stake in Blueprint Medicines Co (NASDAQ:BPMC)

Avidity Partners Management LP lessened its stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 18.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 615,000 shares of the biotechnology company’s stock after selling 136,600 shares during the quarter. Blueprint Medicines accounts for approximately 2.1% of Avidity […]

Avidity Partners Management LP Has $56 73 Million Stake in Blueprint Medicines Co (NASDAQ:BPMC)

Avidity Partners Management LP decreased its position in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 18.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 615,000 shares of the biotechnology company’s stock after selling 136,600 shares during the quarter. Blueprint Medicines comprises […]

Eagle Asset Management Inc Boosts Stake in Blueprint Medicines Co (NASDAQ:BPMC)

Eagle Asset Management Inc. raised its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 10.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 231,396 shares of the biotechnology company’s stock after acquiring an additional 22,279 […]

Blueprint Medicines Co (NASDAQ:BPMC) Receives $103 94 Average Target Price from Analysts

Shares of Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seventeen research firms that are currently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation, nine have given a buy recommendation and […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.